By Jennifer Rigby and Richa Naidu LONDON (Reuters) - (This June 29 story has been corrected to drop the reference to aspartame being removed from PepsiCo products in 2020, in paragraph 25. A PepsiCo spokesperson corrected an earlier statement from…
By David Shepardson WASHINGTON (Reuters) - The United States Postal Service (USPS) is hiking the price of first-class mail stamps to 66 cents from 63 cents effective Sunday. This is the latest in a series of price increases to help…
By Jody Godoy (Reuters) - Twitter's claim that Meta Platforms stole trade secrets to build its new microblogging site may be the first volley in a legal battle between the social media giants, but experts say Twitter would have to…
By Rachel Nostrant (Reuters) - Nearly half of U.S. tap water samples contain toxic "forever chemicals," substances used in hundreds of household items from cleaning supplies to pizza boxes to which broad exposure can carry serious health risks, according to…
OTTAWA (Reuters) - U.S. and Canadian authorities issued a joint advisory on Thursday warning about a widespread increase in the use of a type of malware called Truebot to target organizations in the two countries. "Cyber threat actors are using…
By Emma Farge GENEVA (Reuters) - Nadine, a social robot powered by Artificial Intelligence (AI) with human-like gestures and expressions, could have an important future role to play in tending to the sick and elderly, according to a professor who…
By Valerie Volcovici WASHINGTON (Reuters) -The Biden administration on Wednesday approved construction of an offshore windfarm that will generate 1,100 megawatts of power from up to 98 turbines off the coast of Atlantic City, New Jersey, becoming the third such…
By Valerie Volcovici (Reuters) - The Biden administration's climate agenda is facing an unexpected challenge in drought-prone Corpus Christi, Texas, where a proposed clean hydrogen hub would require the installation of energy-intensive, expensive and potentially environmentally damaging seawater desalination plants.…
By Nathan Gomes (Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical's gene therapy for severe hemophilia A, the company said, giving patients with the inherited bleeding disorder an alternative to regular injections of missing blood proteins.…
By Jesús Aguado, David Latona and Padraic Halpin (Reuters) -U.S. central bankers are likely to resume their rate hike campaign after a break earlier this month, Federal Reserve Chair Jerome Powell signaled on Thursday, as a fresh slew of stronger-than-expected…